Correlation Between Cardiff Oncology and Inovio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiff Oncology and Inovio Pharmaceuticals, you can compare the effects of market volatilities on Cardiff Oncology and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Inovio Pharmaceuticals.
Diversification Opportunities for Cardiff Oncology and Inovio Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cardiff and Inovio is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Inovio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cardiff Oncology and Inovio Pharmaceuticals
Given the investment horizon of 90 days Cardiff Oncology is expected to generate 1.12 times more return on investment than Inovio Pharmaceuticals. However, Cardiff Oncology is 1.12 times more volatile than Inovio Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Inovio Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 134.00 in Cardiff Oncology on September 2, 2024 and sell it today you would earn a total of 127.00 from holding Cardiff Oncology or generate 94.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardiff Oncology vs. Inovio Pharmaceuticals
Performance |
| Timeline |
| Cardiff Oncology |
| Inovio Pharmaceuticals |
Cardiff Oncology and Inovio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardiff Oncology and Inovio Pharmaceuticals
The main advantage of trading using opposite Cardiff Oncology and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.| Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
| Inovio Pharmaceuticals vs. Novavax | Inovio Pharmaceuticals vs. Vaxart Inc | Inovio Pharmaceuticals vs. Enveric Biosciences | Inovio Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |